Filter
1093
Filtered Results: 1093
Text search:
reagents
Featured
Recommendations
131
New Publications
325
Language
Document type
No document type
620
Guidelines
186
Studies & Reports
123
Strategic & Response Plan
69
Manuals
64
Fact sheets
12
Training Material
9
Situation Updates
8
Brochures
1
Infographics
1
Countries / Regions
India
72
Brazil
34
Ethiopia
33
Kenya
30
Nigeria
29
Tanzania
29
Malawi
27
Uganda
27
Sierra Leone
25
Liberia
25
Africa
22
Rwanda
20
Global
20
Ghana
19
Zimbabwe
19
Mozambique
18
Western and Central Europe
18
Zambia
18
Latin America and the Carribbean
17
Nepal
15
Bangladesh
13
Congo, Democratic Republic of
12
West and Central Africa
12
East and Southern Africa
12
Senegal
9
Eastern Europe
9
Syria
8
South Africa
8
Namibia
8
Angola
8
Botswana
8
Ukraine
7
Lesotho
7
Burkina Faso
7
Myanmar / Burma
7
Haiti
6
Cambodia
6
Venezuela
6
Western Pacific Region
6
Middle East and North Africa
5
Russia
5
Indonesia
5
Eswatini/ Swaziland
5
Colombia
4
Guinea
4
USA
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Cameroon
3
Albania
3
Peru
3
Philippines
3
Guinea-Bissau
3
Germany
3
Iraq
3
Pakistan
3
Togo
2
Afghanistan
2
Asia
2
Turkmenistan
2
Bolivia
2
Argentina
2
Papua New Guinea
2
Sri Lanka
2
Yemen
2
Mali
2
South Sudan
2
Somalia
2
Madagascar
2
Tajikistan
1
Timor Leste/ East Timor
1
Turkey
1
Benin
1
Chile
1
Iran
1
Fiji
1
Burundi
1
Mongolia
1
North America
1
Japan
1
Mauritius
1
Portugal
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Sudan
1
Georgia
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
103
Pharmacy & Technologies
79
Key Resources
37
Public Health
35
Women & Child Health
13
Capacity Building
5
Toolboxes
COVID-19
131
TB
110
Rapid Response
83
HIV
80
NTDs
45
AMR
44
Pharmacy
39
Ebola
29
Planetary Health
17
Zika
15
Cholera
14
Caregiver
14
Natural Hazards
13
Conflict
9
Polio
8
Mental Health
7
Health Financing Toolbox
5
Refugee
4
NCDs
3
Global Health Education
3
Specific Hazards
2
Typhoon
1
WHO Technical Series 971
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A...
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Africa CDC Non Communicable Diseases, Injuries Prevention and Control and Mental Health Promotion Strategy
recommended
Non-communicable diseases (NCDs) & injuries and mental health conditions constitute a serious impediment to achieving the vision of Agenda 2063 to build an integrated, prosperous, and peaceful Africa driven by its own citizens. Each year, these conditions cause millions of premature deaths and disab...
Assessment Report
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
On September 10, 2022, the Ministry of Health (MOH) announced a cholera outbreak in Aleppo governorate with 15 laboratory confirmed cases reported between August 25 and September 9, 2022. Activities under this plan seek to address the immediate needs stemming from this outbreak and highlight respons...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
The Global Task Force on Cholera Control (GTFCC) launched Ending Cholera: A Global
Roadmap to 2030 (Global Roadmap) (1), a strategy that aims to reduce global cholera
deaths by 90% and eliminate the disease in at least 20 countries by 2030. It is
organized according to three main axes:
• E...
Le Groupe spécial mondial de lutte contre le choléra (GTFCC) a lancé Mettre fin au choléra :
Une feuille de route mondiale pour 2030 (la Feuille de route mondiale) (1). Cette stratégie vise
à réduire de 90 % le nombre de décès dus au choléra dans le monde et à mettre fin à la
malad...
Après plus de trois ans sans cas, Haïti a signalé le 2 octobre 2022 un ensemble de cas de choléra dans la zone métropolitaine de Port-au-Prince, alors que le pays était sur le point d'être déclaré exempt de choléra.
Cette résurgence du choléra en Haïti survient dans un contexte opér...
